Philips Launches Breakthrough Ultrasound Technology with Advanced AI for Heart Imaging
Royal Philips has introduced Transcend Plus, the latest upgrade to its EPIQ CVx and Affiniti CVx cardiovascular ultrasound systems.
The release delivers significant improvements in 2D and 3D imaging alongside a growing suite of FDA-cleared artificial intelligence applications, designed to help cardiology teams manage increasing workloads and rising clinical demands.
Transcend Plus enhances image sharpness, contrast and anatomical detail, providing clinicians with greater clarity when assessing cardiac structure and function.
These improvements include new 2D Auto EF Advanced capabilities, enabling more precise evaluation of cardiac function in challenging cases.
The platform now integrates 26 FDA-cleared AI applications—more than any other cardiovascular ultrasound system—covering a wide range of tasks from contrast imaging to chamber quantification.
These tools are designed to streamline workflows by automating time-intensive measurements, delivering consistent and reproducible results while reducing the burden on clinical staff.
With healthcare systems facing higher patient volumes, growing complexity of cardiac disease, and persistent staffing pressures, Transcend Plus aims to support faster, more confident decision-making across the continuum of care, from acute hospital settings to outpatient follow-up.
Building on the original Transcend launch, the Plus version positions Philips at the forefront of cardiovascular ultrasound, combining intelligent automation with industry-leading image quality to strengthen diagnostic confidence and efficiency in modern cardiac care.